Joseph Driscoll's Insider Trades & SAST Disclosures
Joseph Driscoll's most recent trade in Organogenesis Holdings Inc - Ordinary Shares - Class A was a trade of 25,000 Class A Common Stock done at an average price of $5.1 . Disclosure was reported to the exchange on March 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joseph Driscoll.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Organogenesis Holdings Inc... | Michael Joseph Driscoll | Director | Sale of securities on an exchange or to another person at price $ 5.10 per share. | 04 Mar 2025 | 25,000 | 166,879 (0%) | 0% | 5.1 | 127,535 | Class A Common Stock |
| Organogenesis Holdings Inc... | Michael Joseph Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 49,575 | 191,879 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Joseph Driscoll Michael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 51,020 | 142,304 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Michael Joseph Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 65,737 | 91,284 (0%) | 0% | 0 | Class A Common Stock | |
| Akoya Biosciences Inc | Joseph Driscoll | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2022 | 250,000 | 110,958 | - | - | Employee Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Joseph Driscoll | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.44 per share. | 22 Dec 2022 | 250,000 | 262,500 | - | 0.4 | 110,000 | Common Stock |
| Akoya Biosciences Inc | Joseph Driscoll | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.44 per share. | 14 Dec 2022 | 14,574 | 27,074 | - | 0.4 | 6,413 | Common Stock |
| Akoya Biosciences Inc | Joseph Driscoll | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2022 | 14,574 | 108,712 | - | - | Employee Stock Option (Right to Buy | |
| Akoya Biosciences Inc | Joseph Driscoll | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.45 per share. | 14 Dec 2022 | 14,574 | 12,500 | - | 12.5 | 181,519 | Common Stock |
| Akoya Biosciences Inc | Joseph Driscoll | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.67 per share. | 14 Dec 2022 | 10,039 | 12,500 | - | 12.7 | 127,187 | Common Stock |
| Akoya Biosciences Inc | Joseph Driscoll | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.44 per share. | 14 Dec 2022 | 10,039 | 22,539 | - | 0.4 | 4,417 | Common Stock |
| Akoya Biosciences Inc | Joseph Driscoll | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2022 | 10,039 | 123,466 | - | - | Employee Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Michael Joseph Driscoll | Director | Purchase of securities on an exchange or from another person at price $ 4.80 per share. | 12 Aug 2022 | 5,000 | 25,547 (0%) | 0% | 4.8 | 24,000 | Class A Common Stock |
| Organogenesis Holdings Inc... | Michael Joseph Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 20,547 | 20,547 (0%) | 0% | 0 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges